Therapeutic Asset Ratings
8,586 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Azacitidine
Polycythemia Vera
M.D. Anderson Cancer Center
P1/2
B
(57)
Azacitidine
Solid Tumors
National University Hospital, Singapore
P1/2
B
(57)
Bavdegalutamide
Prostate Cancer Metastatic
Arvinas Androgen Receptor, Inc.
P1/2
B
(57)
Benadryl
Inert B-cell Lymphoma Transformed Into Large B-cell Lymphoma (Excluding Richter Transformation, THRLBCL, and BL)
Institute of Hematology & Blood Diseases Hospital, China
P1/2
B
(57)
Blinatumomab
Recurrent Burkitt Lymphoma
National Cancer Institute (NCI)
P1/2
B
(57)
Calcium folinate pentahydrate
Mucositis
Tanta University
P1/2
B
(57)
Camizestrant
ER+ HER2- Advanced Breast Cancer
AstraZeneca
P1/2
B
(57)
Capecitabine
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
P1/2
B
(57)
Capecitabine
Recurrent Adult Soft Tissue Sarcoma
OHSU Knight Cancer Institute
P1/2
B
(57)
Carboplatin
Recurrent Squamous Cell Carcinoma of the Larynx
Rapa Therapeutics LLC
P1/2
B
(57)
Carboplatin
Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
Rapa Therapeutics LLC
P1/2
B
(57)
Carboplatin
Recurrent Squamous Cell Carcinoma of the Nasopharynx
Rapa Therapeutics LLC
P1/2
B
(57)
Cetuximab
Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary
Hummingbird Bioscience
P1/2
B
(57)
Cetuximab
Recurrent Small Intestine Cancer
Allist Pharmaceuticals, Inc.
P1/2
B
(57)
CIS-DIAMMINEDICHLOROPLATINUM II
Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme)
Eli Lilly and Company
P1/2
B
(57)
CIS-DIAMMINEDICHLOROPLATINUM II
Metastatic Malignant Neoplasm in the Lung
Roswell Park Cancer Institute
P1/2
B
(57)
CIS-DIAMMINEDICHLOROPLATINUM II
Metastatic Soft Tissue Sarcoma
Roswell Park Cancer Institute
P1/2
B
(57)
CIS-DIAMMINEDICHLOROPLATINUM II
Pancreatic Metastasis
Shanghai Runshi Pharmaceutical Technology Co., Ltd
P1/2
B
(57)
Cyclophosphamide
Adult Solid Tumor
Letolab
P1/2
B
(57)
Cyclophosphamide
CD19 Positive
Jonsson Comprehensive Cancer Center
P1/2
B
(57)
Cyclophosphamide
Kaposi Sarcoma
Essen Biotech
P1/2
B
(57)
Cyclophosphamide
Locally Advanced Cervical Carcinoma
City of Hope Medical Center
P1/2
B
(57)
Cyclophosphamide
Malignant Solid Tumor
Genmab
P1/2
B
(57)
Cyclophosphamide
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Peking University People's Hospital
P1/2
B
(57)
Cyclophosphamide
Stage IVB Bladder Cancer AJCC v8
M.D. Anderson Cancer Center
P1/2
B
(57)
Showing 101 to 125 of 8,586 assets
Previous
Page 5 of 344
Next